Anosmia and ageusia are emerging as symptoms in patients with COVID-19: What does the current evidence say?
- PMID: 32269598
- PMCID: PMC7134577
- DOI: 10.3332/ecancer.2020.ed98
Anosmia and ageusia are emerging as symptoms in patients with COVID-19: What does the current evidence say?
Abstract
There have been several reports noting anosmia and ageusia as possible symptoms of COVID-19. This is of particular interest in oncology since patients receiving some cancer treatments such as chemotherapy or immune therapy often experience similar symptoms as side-effects. The purpose of this report was to summarise the evidence on the existence of anosmia and ageusia an emerging COVID-19 symptoms in order to better inform both oncology patients and clinicians. Currently, there is no published evidence or case reports noting anosmia or ageusia as symptoms of COVID-19. Nevertheless, experts in rhinology have suggested that the onset of such symptoms could either act as a trigger for testing for the disease where possible, or could be a new criterion to self-isolate. Whilst more data is currently needed to strengthen our knowledge of the symptoms of COVID-19, oncology patients who are concerned about anosmia or ageusia in the context of their systemic anti-cancer therapy should contact their acute oncology support line for advice.
Keywords: COVID-19; ageusia; anosmia; smell; taste.
© the authors; licensee ecancermedicalscience.
Conflict of interest statement
None to be declared.
References
-
- Hopkins C, Kumar N. Loss of sense of smell as marker of COVID-19 infection. ENT UK. 2020. [26/03/2020]. [ https://www.entuk.org/sites/default/files/files/Loss of sense of smell a...] - PMC - PubMed
-
- Rabin R. Lost sense of smell may be peculiar clue to coronavirus infection. The New York Times. 2020. [26/03/2020]. [ https://www.nytimes.com/2020/03/22/health/coronavirus-symptoms-smell-tas...]